Trial Profile
A phase 1, single-center, randomized, double-blind, placebo-controlled, positive-controlled, parallel group study evaluating the cardiac safety of Ozanimod in healhy subjects
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 16 Apr 2018
Price :
$35
*
At a glance
- Drugs Ozanimod (Primary) ; Moxifloxacin
- Indications Crohn's disease
- Focus Adverse reactions; Pharmacokinetics
- Sponsors Receptos
- 16 Apr 2018 New trial record
- 01 Apr 2018 Results published in the Clinical Pharmacology in Drug Development